This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: Shire Human Genetic Therapies, Inc.. Active years: 2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2012
Title: Thomas Dierks: Innovator in Genetic Therapies
Introduction
Thomas Dierks is a prominent inventor based in Göttingen, Germany. He has made significant contributions to the field of genetic therapies, particularly in the diagnosis and treatment of sulfatase deficiencies. His work has the potential to impact many lives by addressing critical health issues.
Latest Patents
Dierks holds a patent for a "Cell that expresses a sulfatase and a formylglycine generating enzyme." This invention relates to methods and compositions for the diagnosis and treatment of Multiple Sulfatase Deficiency (MSD) as well as other sulfatase deficiencies. More specifically, the invention involves isolated molecules that modulate post-translational modifications on sulfatases, which are essential for proper sulfatase function. He has 1 patent to his name.
Career Highlights
Thomas Dierks is associated with Shire Human Genetic Therapies, Inc., where he continues to advance research in genetic therapies. His innovative work has garnered attention in the scientific community and has paved the way for new therapeutic approaches.
Collaborations
Dierks has collaborated with notable scientists such as Andrea Ballabio and Kurt Von Figura. These partnerships have enriched his research and contributed to the development of groundbreaking therapies.
Conclusion
Thomas Dierks is a key figure in the field of genetic therapies, with a focus on addressing sulfatase deficiencies. His innovative patent and collaborations highlight his commitment to advancing medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile